Microchips

Product Overview

Development Status: Active Development

Target: Female

Mode: Hormonal

Delivery Type: Subdermal

Duration Type: Long-acting

Description: A contraceptive microchip that is implanted under the skin and continuously releases a progestin for as long as 16 years. It is also programmable such that the release of progestin can be turned on and off by the user or provider.

Updated date: May 30, 2018

Vertical Tabs

Status

Project Phase: Discovery

Project Stage: Target ID/Validation

Began discovery in: 2013

Status Details:
  • Microchips is also developing their technology for other therapeutic areas.

Download Product Report